What Researchers Did
The researchers reviewed 16 studies on non-surgical treatments for osteonecrosis (bone tissue death from poor blood supply) of the hip and knee, including hyperbaric oxygen.
What They Found
This systematic review of 16 studies found that non-surgical treatments, including hyperbaric oxygen, were linked to improvements or slower disease progression in hip and knee osteonecrosis, mainly in early stages. The studies were found through searches of four databases from January 2001 to November 2015. Among the treatments assessed, hyperbaric oxygen, extracorporeal shockwave therapy and pulsed electromagnetic field therapy were each reported to delay and partly reverse disease progression. Bisphosphonates were linked to less pain and a lower rate of bone necrosis, and enoxaparin was linked to curbed progression. The review states that at stage III and beyond, these conservative treatments are no longer viable options.
What This Means for Canadian Patients
For people with hip or knee osteonecrosis, the abstract says stage I and II disease, before the bone surface collapses, can be approached with drug or biophysical treatments before more invasive measures such as core decompression are considered. Hyperbaric oxygen is one of the biophysical options reported to delay and partly reverse progression. The abstract does not give hyperbaric oxygen pressures or session counts, and it does not say which option works best. It notes that the best balance of cost, risk and benefit is still undetermined.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract says the best treatment in terms of cost, risk and benefit is still unknown and no standard of care exists, and it gives no details on the quality or design of the 16 included studies, so the strength of the evidence is unclear.